openPR Logo
Press release

Critical Information Regarding Bextra Side Effects Available Online

01-09-2006 08:55 AM CET | Health & Medicine

Press release from: Bextra Lawsuit

Website publishes critical information about Bextra, a medicine that is the cause of many lawsuits.

ARIZONA, "Bextra Lawsuit" A website created to help people with their legal concerns about this product has published some important information relating Bextra. "Bextra is the trade name for the pharmaceutical valdecoxib that was created by G.D Searle & Company to combat pain suffered by those with rheumatoid and osteoarthritis, as well as serious menstrual pain attacks" says Derek Gerb, site writer " Bextra is one of the many drugs marketed through the pharmaceutical company Pfizer. Aside from minimal side effects , the drug has been proven to be extremely successful in minimizing arthritis pain. Like ibuprofen and naproxen sodium, Bextra is considered a non-steroidal, anti-inflammatory drug (NSAID) as well as a Cox-2 inhibitor. Bextra is a prescription drug that can only be legally distributed on the advice of a doctor. As with any drug, Bextra side effects have been shown to affect a small number of the patients who have taken the drug."

Risk Factors and Bextra Side Effects

Bextra is not intended to be prescribed for everyone. If you have shown an allergic reaction to previous NSAID drugs, or are allergic to any of Bextra's ingredients, you should not take this drug. Additionally, all NSAID drugs can negatively impact the liver, so people with existing liver problems should stay away from Bextra. As one of the common side effectcts of bextra is fluid retention, people with high blood pressure or heart problems should avoid using Bextra as it will exacerbate the problem. As with all NSAID drugs, stomach ulcers and bleeding are one of the possible effects. Patients with current stomach disorders should not take Bextra.

Additional Bextra Side Effects

Clinical tests have shown that there are several Bextra side effects to be aware of while taking the drug. While these side effects did not bother most patients, a small percentage experienced one or more Bextra side effects . If any side effects or symptoms appear, patients are instructed to notify their doctor immediately. Bextra side effects have been known to include:

* Stomach or abdominal pain
* Black stool
* Vomit with the appearance of blood or coffee grounds
* Indigestion/Nausea
* Headache
* Diarrhea
* Rash
* Fatigue
* Jaundice
* Fluid retention/swelling of extremities

As with any drug, pregnant or nursing mothers should notify your doctor prior to being prescribed Bextra. Additionally, doctors should be made fully aware of current prescriptions you are taking and any existing health problems that could affect the benefits of taking Bextra.

While Pfizer has noted that it does not agree with the severity of the findings, it has pulled Bextra from distribution in deference to the need for additional studies and testing.



For More Information Contact:

Derek Gerb
derek_hrrg@hotmail.com
http://bextra-lawsuit.org/sitemap.html

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Critical Information Regarding Bextra Side Effects Available Online here

News-ID: 2518 • Views:

More Releases for NSAID

NSAID API Market, Strategic Developments, Demand Surge in Chronic Pain Treatment …
Overview of the NSAID API Market The global NSAID (Nonsteroidal Anti-inflammatory Drug) Active Pharmaceutical Ingredients (API) market is witnessing significant momentum, primarily driven by increasing incidences of chronic pain, arthritis, and inflammatory diseases worldwide. These APIs serve as the core components in formulating a wide range of prescription and over-the-counter analgesic medications. As the burden of non-communicable diseases rises globally, especially among the aging population, the demand for NSAID-based treatments has
NSAID Ophthalmic Drugs Latest Market Analysis Report 2025
On Mar 12, 2025, Global Info Research released a research report titled "Global NSAID Ophthalmic Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the NSAID Ophthalmic Drugs market from 2020 to 2031. Including the market size and development trends of NSAID Ophthalmic Drugs Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it
Global NSAID Ophthalmic Drugs Market Analysis By Major Manufacturers and Competi …
Globally, NSAID Ophthalmic Drugs key manufacturers include AbbVie, Bausch Health, Bayer, Dossa Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, Pfizer and Sun Pharmaceutical Industries, etc. AbbVie, Bausch Health, Bayer are top 3 players and held % sales share in total in 2022 Global NSAID Ophthalmic Drugs Market: Driven factors and Restrictions factors The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of
Non-steroidal Anti-inflammatory Drugs (NSAID) Market Will Escalate Rapidly In Th …
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2022 research report initially provides a basic overview of the Market that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Request sample pages of this research study at - https://www.theinsightpartners.com/sample/TIPRE00004421/?utm_source=OpenPR&utm_medium=10366 The non-steroidal anti-inflammatory drugs are a type of pain reliever that help to reduce inflammation and lower fevers. The NSAIDs are the most prescribed medications, which are
Global NSAID API Market Size,Depth Research Report 2022-2028|Novartis, Pfizer, B …
Global Market For NSAID API Estimated At US$ Million In The Year 2022, Is Projected To Reach A Revised Size Of US$ Million By 2028, Growing At A CAGR Of %  During The Forecast Period 2022-2028. Los Angeles, United States October 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global NSAID API market. It sheds light on how the
IoT (Internet Of Medical Things) To Be The Buzzword For NSAID API Market
An Active Pharmaceutical Ingredient (API) is a bulk drug used as an ingredient in a dosage form. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that group together drugs that provide analgesic (analgesic) and antipyretic (reducing fever) effects and, at high doses, anti-inflammatory effects. Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/17038 The term nonsteroidal distinguishes these drugs from steroids, which have similar eicosanoid inhibitory, anti-inflammatory properties, among a wide